bpc-157 unapproved drug fda statement issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA panel narrowly backs unapproved
FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers WDSU Advisers to the FDA back broad access to unapproved peptides, despite agency concerns KPBS Public Media FDA to weigh easing limits on unproven peptides FDA panel backs compounded BPC 157, KPV peptides in win for RFK Jr. STAT FDA advisers weigh relaxing rules on three more peptides to widen access Reuters
Pay in 4 interest-free payments of $6.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22



